Abstract
Generally speaking, we cannot fully understand the mechanisms of general anesthesia until the molecular mechanisms of consciousness are fully elucidated. Loss of consciousness induced by general anesthetics might involve sensation, motor activity, behavior, memory and self-consciousness. The effects of many anesthetics are not limited to humans but also extend to the animals. Similar levels of minimum anesthetic concentrations are required to induce anesthesia in animals and human, i.e., the minimum alveolar concentration (MAC). Such similarity probably reflects identical anesthetic target molecules and functional conservation based on gene conservation. Thus, to study the mechanisms of anesthetic action, various animal models that are accessible to genetic manipulation, such as nematodes (Caenorhabditis elegans), fruit flies (Drosophila) and mice can be used. Genetic techniques allow for the rapid identification and characterization of genes involved in the actions of general anesthetics. In this review, I will describe the genetic mutations and putative target genes of general anesthetics.
Current Drug Targets
Title: Studies on Target Genes of General Anesthetics
Volume: 3 Issue: 1
Author(s): Sumiko Gamo
Affiliation:
Abstract: Generally speaking, we cannot fully understand the mechanisms of general anesthesia until the molecular mechanisms of consciousness are fully elucidated. Loss of consciousness induced by general anesthetics might involve sensation, motor activity, behavior, memory and self-consciousness. The effects of many anesthetics are not limited to humans but also extend to the animals. Similar levels of minimum anesthetic concentrations are required to induce anesthesia in animals and human, i.e., the minimum alveolar concentration (MAC). Such similarity probably reflects identical anesthetic target molecules and functional conservation based on gene conservation. Thus, to study the mechanisms of anesthetic action, various animal models that are accessible to genetic manipulation, such as nematodes (Caenorhabditis elegans), fruit flies (Drosophila) and mice can be used. Genetic techniques allow for the rapid identification and characterization of genes involved in the actions of general anesthetics. In this review, I will describe the genetic mutations and putative target genes of general anesthetics.
Export Options
About this article
Cite this article as:
Sumiko Gamo , Studies on Target Genes of General Anesthetics, Current Drug Targets 2002; 3 (1) . https://dx.doi.org/10.2174/1389450023348118
DOI https://dx.doi.org/10.2174/1389450023348118 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Clinical Uses of Melatonin: Evaluation of Human Trials
Current Medicinal Chemistry Contribution of Inflammatory Processes to Nerve Cell Toxicity by Bilirubin and Efficacy of Potential Therapeutic Agents
Current Pharmaceutical Design Polymer-Based Drug Delivery Devices for Neurological Disorders
CNS & Neurological Disorders - Drug Targets Patent Annotations
Recent Patents on Anti-Cancer Drug Discovery Functional Food with Some Health Benefits, So Called Superfood: A Review
Current Nutrition & Food Science Ion Channels as Medicinal Targets of Biological Toxins: The Impact of Automated Patch-Clamp Electrophysiology
Current Topics in Medicinal Chemistry Critical Role of the Endocannabinoid System in the Regulation of Food Intake and Energy Metabolism, with Phylogenetic, Developmental, and Pathophysiological Implications
Endocrine, Metabolic & Immune Disorders - Drug Targets mTOR Inhibitors in Tuberous Sclerosis Complex
Current Neuropharmacology Differences in Functional Brain Activation and Hippocampal Volume Among Amnestic Mild Cognitive Impairment Subtypes
Current Alzheimer Research Adult Neurogenic and Antidepressant Effects of Adiponectin: A Potential Replacement for Exercise
CNS & Neurological Disorders - Drug Targets A Review on Hematopoietic Stem Cell Treatment for Epilepsy
CNS & Neurological Disorders - Drug Targets MCI Patients Declining and Not-Declining at Mid-Term Follow-Up: FDG-PET Findings
Current Alzheimer Research Involvement of the Blood-Brain Barrier in Metabolic Regulation
CNS & Neurological Disorders - Drug Targets Role of Grina/Nmdara1 in the Central Nervous System Diseases
Current Neuropharmacology Ectonucleotidases and Nucleotide/Nucleoside Transporters as Pharmacological Targets for Neurological Disorders
CNS & Neurological Disorders - Drug Targets Unraveling Progesterone-Induced Molecular Mechanisms in Physiological and Pathological Conditions
Current Clinical Pharmacology Recent Advances in Epilepsy
Current Neuropharmacology Fluorescent Dyes for Bio-Applications in the Patent Literature
Recent Patents on Materials Science Cardiovascular Complications in Patients with Klinefelter’s Syndrome
Current Pharmaceutical Design Design, Synthesis of 6-Substituted-pyrido[3,2-d]pyridazine Derivatives with Anticonvulsant Activity
Medicinal Chemistry